title: Editorial comment to Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
authors.affiliation: Division of Urology, Mushashino Red Cross Hospital, Tokyo, Japan. tsurumaki-jua@umin.ac.jp.
authors.forename: Yuzuri Tsurumaki
authors.initials: YT
authors.lastname: Sato
mesh_terms: D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000097:blood* / Q000473:pathology*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000473:pathology*
chemical_list: D017430:Prostate-Specific Antigen